Weiss Multi Strategy Advisers LLC Immunovant, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$31.31 - $44.19 $1.41 Million - $1.99 Million	45,029 Added 147.14%	75,631 $3.19 Million
Q3 2023 Nov 14, 2023	SELL	$18.55 - $39.96 $1.9 Million - $4.08 Million	-102,174 Reduced 76.95%	30,602 $1.18 Million
Q2 2023 Aug 14, 2023	SELL	$14.2 - $23.75 $421,030 - $704,187	-29,650 Reduced 18.25%	132,776 $2.52 Million
Q1 2023 May 15, 2023	BUY	$15.27 - $19.72 $1.41 Million - $1.82 Million	92,420 Added 132.02%	162,426 $2.52 Million
Q4 2022 Feb 14, 2023	BUY	$6.59 - $17.75 $461,339 - $1.24 Million	70,006 New	70,006 $1.24 Million

211

66.9M

2.3M

631K

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.